Stocks and Investing Stocks and Investing
Fri, August 13, 2021

Serge Belanger Maintained (TRVI) at Strong Buy with Decreased Target to $10 on, Aug 13th, 2021


Published on 2024-10-27 17:38:29 - WOPRAI, Serge Belanger
  Print publication without navigation


Serge Belanger of Needham, Maintained "Trevi Therapeutics, Inc." (TRVI) at Strong Buy with Decreased Target from $12 to $10 on, Aug 13th, 2021.

Serge, nor any peers, have made any analyst calls on TRVI in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources